Parathyroid adenomas and cardiovascular risk.

in Endocrine-Related Cancer
Authors:
N Garcia de la Torre Department of Endocrinology, The Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Headington OX3 7LJ, UK.

Search for other papers by N Garcia de la Torre in
Current site
Google Scholar
PubMed Close
,
J A H Wass Department of Endocrinology, The Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Headington OX3 7LJ, UK.

Search for other papers by J A H Wass in
Current site
Google Scholar
PubMed Close
, and
H E Turner Department of Endocrinology, The Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Headington OX3 7LJ, UK.

Search for other papers by H E Turner in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 10: Issue 2
Article Type:
Abstract
Page Range:
309–322
Online Publication Date:
Jun 2003
Free access

Sign up for journal news

In recent decades, primary hyperparathyroidism (pHPT) has changed its clinical presentation from a disease with bone and renal involvement to a frequently asymptomatic disorder detected on routine biochemistry. Nevertheless, it remains unclear whether patients with untreated mild asymptomatic hyperparathyroidism are at risk for other complications such as increased morbidity and mortality from cardiovascular diseases. There are limited data on the incidence of cardiovascular abnormalities in mild pHPT. However, pHPT has been associated with increased risk of death from cardiovascular disease, hypertension, left ventricular hypertrophy (LVH), valvular and myocardial calcifications, impaired vascular reactivity, alterations in cardiac conduction, impaired glucose metabolism, dyslipidaemia, and alterations in body composition. The nature of some of these associations is in question, because cure of pHPT does not lead to improvement of the cardiovascular disorder e.g. hypertension. In contrast, currently available data suggest that LVH, impaired glucose metabolism and dyslipidaemia may improve after surgery and that successful parathyroidectomy could decrease the excess mortality in patients with pHPT due to cardiovascular disease.

Endocrine-Related Cancer is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 894 573 0
PDF Downloads 273 78 0

 

  • Collapse
  • Expand
Print ISSN:
1351-0088
Online ISSN:
1479-6821
Page(s):
14
Print Publication Date:
01 Jan 2003
Online Publication Date:
Jun 2003